A surprising new study suggests the shingles shot may do more than prevent illness—it could also slow biological aging in older adults

What the Study Found

A new observational study published in The Journals of Gerontology Series A: Biological Sciences and Medical Sciences analyzed health data from 3,884 U.S. adults aged 70 and older to understand how receiving the shingles vaccine relates to biological aging. (geron.org)

Researchers looked at seven different biomarkers of aging, including:

• Inflammation levels

• Innate and adaptive immunity

• Cardiovascular function

• Neurodegeneration markers

• Epigenetic aging (gene regulation changes)

• Transcriptomic aging (gene expression changes)

• Overall composite biological aging score (geron.org)

The study found that vaccinated participants generally had:

• Lower inflammation levels

• Slower epigenetic and transcriptomic aging

• Better composite biological aging scores

compared with those who had not received the vaccine — even after adjusting for health and lifestyle factors. (geron.org)

Why This Matters

Instead of just preventing shingles, the vaccine appears to influence biological systems associated with aging. One key hypothesis is that the vaccine reduces chronic, low-grade inflammation — sometimes called “inflammaging” — which contributes to cardiovascular disease, cognitive decline, and frailty in older adults. (insideprecisionmedicine.com)

While chronological age refers to how many years a person has lived, biological age reflects how well their cells and systems are functioning. Two 75-year-olds could have very different biological ages: one may function more like someone in their 60s, while the other may show signs of advanced aging. Slowing biological aging could thus have meaningful long-term health benefits. (geron.org)

How the Vaccine Might Slow Aging

Experts believe several mechanisms could explain the effect:

• Reduced chronic inflammation: By preventing latent virus reactivation, the vaccine may lower background inflammation that accelerates aging. (cidrap.umn.edu)

• Improved immune regulation: Vaccination may help the immune system stay more stable and responsive with age. (insideprecisionmedicine.com)

• Persistent benefits: Some effects — especially slower epigenetic and transcriptomic changes — appear to last for years after vaccination. (geron.org)

However, researchers emphasize that correlation doesn’t prove causation. The study was observational, so it cannot definitively show that the vaccine causes slower aging, only that the two are associated. More controlled research, including randomized trials, is needed to confirm the mechanisms. (geron.org)

Implications for Public Health

This study adds to a growing body of research suggesting that adult vaccines — including those for shingles and influenza — might provide broader health benefits beyond infection prevention. For example, some large population studies have linked shingles vaccination with a lower risk of dementia decades later, although mechanisms remain under investigation. (ABC)

Given that shingles vaccines like Shingrix are already recommended for adults over age 50 in many countries, these potential extra benefits could strengthen the case for wider vaccination coverage. (AARP)

Bottom Line

The new research shows that the shingles vaccine may be more than just protection against a painful rash — it might also play a role in supporting healthier aging by slowing biological processes linked to age-related disease. While more research is needed to fully understand the connection, the findings open exciting possibilities for aging and preventive medicine. (geron.org)